Nationwide Cash-Pay GLP-1 Telehealth Platform
Share on Facebook 
Post to X 
Share on LinkedIn 
Share on Reddit Business Description
A profitable, fully remote cash-pay telehealth platform providing medical weight loss (GLP-1 therapies) and longevity care nationwide. Founded 2022. Trailing twelve-month revenue of $1,821,000 (up 36% year over year) at a 66% gross margin, generating $633,000 in seller's discretionary earnings.
The business acquires patients through a network of social-media affiliates paid a 10% lifetime revenue share — it has never relied on paid advertising. In-house nurse practitioners, licensed across all 50 states, review each intake and prescribe to protocol; partner compounding pharmacies drop-ship 3–6 month plans direct to the patient. There is no inventory, no premises, and no capital equipment.
Key selling points:
• Revenue grew from $539,000 (FY2023) to $1,821,000 (TTM), with monthly revenue roughly doubling in the four months after an affiliate manager was hired
• No customer concentration — no single customer exceeds 1% of revenue
• Diversified mix: approximately 60% weight loss, 40% longevity, with longevity growing fastest
• Owner works about five hours per month; a full-time operator runs the business day to day
• A 45,000-member community group, brand, and clinical protocols are included in the sale
• Clear, capital-light growth paths: product extensions, B2B referral partnerships, and entry into the insurance channel
The owner is selling to bring in new operating energy for the next phase and will support a 90–180 day transition, with the option to retain a minority stake.
The business acquires patients through a network of social-media affiliates paid a 10% lifetime revenue share — it has never relied on paid advertising. In-house nurse practitioners, licensed across all 50 states, review each intake and prescribe to protocol; partner compounding pharmacies drop-ship 3–6 month plans direct to the patient. There is no inventory, no premises, and no capital equipment.
Key selling points:
• Revenue grew from $539,000 (FY2023) to $1,821,000 (TTM), with monthly revenue roughly doubling in the four months after an affiliate manager was hired
• No customer concentration — no single customer exceeds 1% of revenue
• Diversified mix: approximately 60% weight loss, 40% longevity, with longevity growing fastest
• Owner works about five hours per month; a full-time operator runs the business day to day
• A 45,000-member community group, brand, and clinical protocols are included in the sale
• Clear, capital-light growth paths: product extensions, B2B referral partnerships, and entry into the insurance channel
The owner is selling to bring in new operating energy for the next phase and will support a 90–180 day transition, with the option to retain a minority stake.
About the Business
- Years in Operation
- 4
- Employees
- 11 (4 Full-time, 7 Contractors)
Fully remote contractor-led model. Nurse practitioners are contracted at $30 per - Currently Relocatable
- Yes
- Currently Home Based
- Yes
- Facilities & Assets
- No premises, no leases, and no capital equipment — the business is fully remote and asset-light. Assets transferring with the sale are intangible: the brand and domain, documented clinical protocols, the affiliate and ambassador network, compounding-pharmacy relationships, the patient and customer list, and a 45,000-member online community group. Operations run on a HIPAA-compliant EHR (patient records and workflow), an e-commerce storefront and checkout, funnel and landing-page software, email and newsletter tooling, a community platform, CRM, and intake-form software. Prescriptions are drop-shipped by partner pharmacies, so no stock is held at any point.
- Market Outlook / Competition
- The GLP-1 market is projected to exceed $95B globally by 2030 (Goldman Sachs), with roughly 1 in 8 US adults having used a GLP-1 (KFF) against a 40% adult obesity rate (CDC). US telehealth is approximately $36B in 2026 and growing above 20% annually (IBISWorld). Demand is shifting from short-course weight loss toward maintenance microdosing and longevity — a structurally more recurring pattern. Competitors fall into three groups: large high-volume telehealth brands that prioritise scale over service; operators that rent third-party provider networks; and paid-advertising-led brands facing rising acquisition costs. This business differentiates on an owned in-house clinical team (enabling custom protocols and fast product launches), affiliate-led distribution rather than paid media, high-touch support at one representative per 150 patients, and an owned 45,000-member community
- Opportunities for Growth
- Five identified levers, none capital-intensive. (1) Product line extensions — hair loss, cosmetics and bloodwork can run through the existing pharmacy and clinical infrastructure; a new product needs only a pharmacy link, a landing page, and a protocol. (2) B2B affiliate partnerships — gyms, personal trainers and nutritionists are an untapped referral channel alongside the current social-media affiliates. (3) Insurance channel entry — the business is cash-pay only today; accepting insurance would unlock materially higher volume in exchange for added regulatory work. (4) Premium bundles — nutrition and training services layered onto the core offering at higher margin. (5) Community monetisation — the 45,000-member group is currently under-utilised. Capacity is not the constraint: customer service scales at low cost with one representative per 150 additional patients, and there is no inventory or capital expenditure attached to growth.
About the Sale
- Seller Motivation
- The owner is seeking new operating energy for the next phase of the business and
- Transition Support
- The owner will remain available for 90–180 days post-close and is open to retaining a minority stake alongside an aligned buyer. The full-time operator, who runs daily operations, marketing and email, will either stay on or support a 120–180 day handover. The seller will make introductions to the nurse practitioner team, pharmacy partners, affiliates, and contract specialists. Clinical protocols, the EHR configuration, and compliance systems are documented and in place, so the transfer is largely relationship and process handover rather than technical rebuild.
Listing Info
- ID
- 2538024
- Listing Views
Attached DocumentsAttachment Disclaimer
Listing ID: 2538024 The information on this listing has been provided by either the seller or a business broker representing the seller. BizQuest has no interest or stake in the sale of this business and has not verified any of the information and assumes no responsibility for its accuracy, veracity, or completeness. See our full Terms of Use. Learn how to avoid scams.
Similar Listings
